Journal article
Elimination of antibodies against coagulation factor VIII: Factor VIIa is the most promising therapeutic alternative.
Authors
Schulman S
Journal
Läkartidningen, Vol. 86, No. 4, pp. 219–221
Publication Date
January 25, 1989
ISSN
0023-7205